Clinical Trials Logo

Hidradenitis clinical trials

View clinical trials related to Hidradenitis.

Filter by:

NCT ID: NCT04648631 Completed - Clinical trials for Hidradenitis Suppurativa

Hidradenitis Suppurativa (HS) Tunneling Wounds

Start date: February 26, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to look at the change in the microbiome (bacterial composition) of an HS tunneling wound and examine if treatment with an antibiofilm surfactant wound gel (ABWG) (a topical medication that will fight bacteria attached to the surface of those tunnels) changes the bacterial composition of the wounds.

NCT ID: NCT04600375 Completed - Clinical trials for Hidradenitis Suppurativa

Evaluating the Effect of a Written Action Plan on Comfort and Understanding of Hidradenitis Suppurativa

Start date: October 20, 2020
Phase: N/A
Study type: Interventional

This study is being conducted to evaluate if a written action plan for hidradenitis suppurativa (HS) will help patients with hidradenitis suppurativa gain a better understanding of the condition and how to manage the condition on a daily basis compared to a routine verbal consultation.

NCT ID: NCT04493502 Completed - Clinical trials for Hidradenitis Suppurativa

A Study of LY3041658 in Adults With Hidradenitis Suppurativa

Start date: August 26, 2020
Phase: Phase 2
Study type: Interventional

The reason for this study is to see if the study drug LY3041658 is effective in participants with moderate-to-severe hidradenitis suppurativa (HS).

NCT ID: NCT04476043 Completed - Clinical trials for Hidradenitis Suppurativa

To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa

Start date: August 25, 2020
Phase: Phase 2
Study type: Interventional

To evaluate the efficacy and safety of INCB054707 in participants with hidradenitis suppurativa over a 16-week placebo-controlled treatment period followed by a 36-week open-label extension period. All eligible participants will be invited to continue treatment for an additional 48-week Long-term extension period (also open label).

NCT ID: NCT04449354 Completed - Clinical trials for Hidradenitis Suppurativa

HidraWear AX HS Study

Start date: October 30, 2019
Phase: N/A
Study type: Interventional

The product, HidraWear AX (www.hidrawear.com) is and adhesive free wound dressing system for the every day home care of Hidradenitis Suppurativa (HS), a debilitating disease of the skin for which there are limited wound dressing products. This is a study to assess the use HidraWear Ax vs current product and method of use, and to determine the impact on patients' quality of life.

NCT ID: NCT04440410 Completed - Dermatitis, Atopic Clinical Trials

Evaluation of Cutaneous and Circulating Inflammatory Biomarkers in Hidradenitis Suppurativa and Atopic Dermatitis

Start date: May 28, 2020
Phase:
Study type: Observational

This non-intervention study will identify the biomarker profiles in hidradenitis suppurativa (HS) and atopic dermatitis (AD) (as a comparator) that would have the most utility in interventional studies evaluating efficacy during therapeutic intervention. Study data will also be used to correlate cellular/molecular changes in blood (cells and serum), and tissue, with clinical/histopathological phenotypes.

NCT ID: NCT04430855 Completed - Clinical trials for Hidradenitis Suppurativa (HS)

A Study of Oral Upadacitinib Tablet Compared to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa to Assess Change in Disease Symptoms

Start date: July 14, 2020
Phase: Phase 2
Study type: Interventional

Hidradenitis suppurativa (HS) is an inflammatory skin disease that causes painful lesions in the axilla (underarm), inguinal (groin) and anogenital (anal and genital) regions. This study will evaluate how well upadacitinib compared to placebo (no medicine) works to treat hidradenitis suppurativa in adult participants with moderate to severe disease. The study will assess change in disease signs and symptoms.

NCT ID: NCT04251663 Completed - Clinical trials for Hidradenitis Suppurativa

Complement C5a Receptors in Hidradenitis Suppurativa

Start date: July 18, 2019
Phase:
Study type: Observational

To study the role of C5a in Hidradenitis Suppurativa (HS). Complement C5a is a major chemotactic factor that stimulates neutrophil infiltration.

NCT ID: NCT04242498 Completed - Clinical trials for Hidradenitis Suppurativa

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

BE HEARD II
Start date: March 2, 2020
Phase: Phase 3
Study type: Interventional

The purpose of the study is to evaluate the efficacy and safety of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (HS)

NCT ID: NCT04242446 Completed - Clinical trials for Hidradenitis Suppurativa

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

BE HEARD I
Start date: February 19, 2020
Phase: Phase 3
Study type: Interventional

The purpose of the study is to evaluate the efficacy and safety of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (HS)